Introducing a new generation of prognostic precision in breast cancer
Helping healthcare professionals guide ER+, HER2− early-stage breast cancer patients toward the appropriate treatment decision
Now Available! Late Recurrence (5 -15 years)
What is EndoPredict?
Now Available! Chemotherapy Benefit
Order EndoPredict Starter Kit
MARKET LEADER IN EUROPE AND
NOW AVAILABLE IN THE UNITED STATES!